IgA nephropathy in a boy with frequently relapsing nephrotic syndrome

CEN Case Rep. 2024 Feb;13(1):14-18. doi: 10.1007/s13730-023-00791-w. Epub 2023 Apr 24.

Abstract

A Japanese boy developed nephrotic syndrome (NS) and had microscopic hematuria at 8 years old. Renal biopsy was performed. Light microscopy study revealed mesangial proliferation and all immunofluorescent stains (including IgA) were negative, so he was diagnosed with non-IgA diffuse mesangial proliferation (DMP). Complete remission was achieved at 13 days after the initiation of oral prednisolone, and hematuria also disappeared 3 days later, but the patient developed frequently relapsing nephrotic syndrome. Cyclosporine A (CyA) was introduced at 10 years old, and there were no relapses between then and when it was discontinued at 12 years old. A second renal biopsy revealed minimal change without CyA nephrotoxicity. However, there was repeated relapse of NS after discontinuation, so CyA was reintroduced 8 months later, and NS remained in remission thereafter. Microscopic hematuria appeared at 13 years old, however, with gross hematuria appearing at the time of infection. A third renal biopsy revealed mesangial proliferation with IgA-dominant deposition, so the patient was diagnosed with IgA nephropathy. Currently (14 years old), CyA treatment has been discontinued and the patient is undergoing lisinopril therapy for IgA nephropathy, but there are still relapses of NS. To the best of our knowledge, there have been no previous reports of a patient with non-IgA DMP at the onset of NS who had later development of IgA nephropathy. The patient showed non-IgA DMP at the onset, suggesting that NS with non-IgA DMP and IgA nephropathy has some common pathophysiology. Treatment for NS, such as PSL and/or CyA treatment, may suppress the clinical manifestation of late IgA nephropathy.

Keywords: Cyclosporine A (CyA); Frequently relapsing nephrotic syndrome (FRNS); IgA nephropathy; Nephrotic syndrome (NS); Non-IgA diffuse mesangial proliferation (DMP).

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Child
  • Chronic Disease
  • Cyclosporine / therapeutic use
  • Glomerulonephritis, IGA* / complications
  • Glomerulonephritis, IGA* / diagnosis
  • Glomerulonephritis, IGA* / drug therapy
  • Hematuria / diagnosis
  • Hematuria / etiology
  • Humans
  • Immunoglobulin A
  • Male
  • Nephrotic Syndrome* / complications
  • Nephrotic Syndrome* / diagnosis
  • Nephrotic Syndrome* / drug therapy
  • Prednisolone / therapeutic use
  • Recurrence

Substances

  • Prednisolone
  • Cyclosporine
  • Immunoglobulin A